Nicole Sinclair is research director, Mad Money and Jim Cramer's researcher at TheStreet. Nicole analyzes stocks and develops a strategic macro outlook, which she incorporates into segment ideas for CNBC's "Mad Money" and supports Jim's other endeavors including "Squawk on the Street" and RealMoney.com. Nicole also writes the "Inside the Madness" blog on cnbc.com.
Previously, she worked as an investment banking analyst for the Industrials Group in Goldman Sachs' New York office. Born and raised in Princeton, New Jersey, Nicole graduated with honors from Harvard College, where she served as executive editor of The Harvard Crimson.
Follow Nicole Sinclair on Twitter @nicoleusinclair.
Is this breakout story on your radar? "Mad Money" host Jim Cramer is about to put it there.
Jim Cramer is always looking for the next big biotech stock. He has found one that is a real game-changer, thanks to this new drug.
Jim Cramer does not want interest rates to rise right now, and lays out the significant repercussions on the globe if they do go up.
Jim Cramer is seeing some good signs in the economy right now. Could they be the perfect ingredients for a Santa Claus rally?
Grab the latest CNBC gear from the NBCUniversal Store!
Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.
You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.